Common use of Studies and Other Preclinical and Clinical Tests Clause in Contracts

Studies and Other Preclinical and Clinical Tests. The studies, tests and preclinical and clinical trials conducted by or on behalf of the Company that are described in the SEC Documents were and, if still pending, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards; the descriptions of the results of such studies, tests and trials contained in the SEC Documents are accurate and complete; and neither the Company nor any of its Subsidiaries has received any notices or correspondence from the FDA or any foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring the termination, suspension or material modification of any studies, tests or preclinical or clinical trails conducted by or on behalf of the Company.

Appears in 2 contracts

Samples: Securities Purchase Agreement (CardioVascular BioTherapeutics, Inc.), Securities Purchase Agreement (Medicor LTD)

AutoNDA by SimpleDocs

Studies and Other Preclinical and Clinical Tests. The studies, tests and preclinical and clinical trials conducted by or on behalf of the Company that are described in the SEC Documents were andwere, and if still pendingpending are, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards; the descriptions of the results of such studies, tests and trials contained in the SEC Documents are accurate and completecomplete in all material respects; and neither the Company nor any of its Subsidiaries has not received any notices or correspondence from the FDA or any foreign, state or local governmental body exercising comparable authority or any Institutional Review Board institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests or preclinical or clinical trails trials conducted by or on behalf of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (LENSAR, Inc.)

Studies and Other Preclinical and Clinical Tests. The studies, tests and preclinical and clinical trials conducted by or on behalf of the Company that are described in or any of the SEC Documents were andSubsidiaries were, and if still pendingpending are, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards; the descriptions of the results of such studies, tests and trials contained in the SEC Documents are accurate and complete; and neither the Company nor any of its the Subsidiaries has received any notices or correspondence from the FDA or any foreign, state or local governmental body exercising comparable authority or any Institutional Review Board institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests or preclinical or clinical trails trials conducted by or on behalf of the CompanyCompany or any of the Subsidiaries.

Appears in 1 contract

Samples: Securities Purchase Agreement (Stereotaxis, Inc.)

AutoNDA by SimpleDocs

Studies and Other Preclinical and Clinical Tests. The studies, tests and preclinical and clinical trials conducted by or on behalf of the Company that are described in or any of the SEC Documents were andSubsidiaries were, and if still pendingpending are, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards; the descriptions of the results of such studies, tests and trials contained in the SEC Documents are accurate and completecomplete in all material respects; and neither the Company nor any of its the Subsidiaries has received any notices or correspondence from the FDA FDA, any other Regulatory Agency or any foreign, state or local governmental body exercising comparable authority or any Institutional Review Board institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests or preclinical or clinical trails trials conducted by or on behalf of the CompanyCompany or any of the Subsidiaries.

Appears in 1 contract

Samples: Securities Purchase Agreement (Proteon Therapeutics Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.